FDANews
FDAnews Device Daily Bulletin

Manhattan Scientifics Unit Partners With University of Michigan to Develop Breast Cancer Diagnostic

Jan. 14, 2016

Manhattan Scientifics’ Senior Scientific unit is joining up with the University of Michigan Medical School to develop a diagnostic for breast cancer detection.

The company is seeking to apply its magnetic relaxometry technology as a sensitive in vivo method for detecting molecular targets associated with specific cancer phenotypes.

Financial terms of the agreement were not disclosed. — Michael Cipriano